Skip to main content
. 2021 Apr 6;21(6):446. doi: 10.3892/ol.2021.12707

Table III.

Univariate analysis of locoregional control duration.

Univariate analysis

Factor Hazard ratio (95% CI) P-value
Age (≥62 years vs. <62 years) 0.630 (0.105–3.792) 0.614
Concurrent chemotherapy (no vs. yes) 0.321 (0.053–1.935) 0.215
FIGO stage (I+II vs. III+IV) 2.104 (0.350–12.638) 0.416
PeLN (positive vs. negative) 1.403 (0.233–8.457) 0.711
PALN (positive vs. negative) 0.126 (0.021–0.757) 0.024
CD8+ TILs (pre-RT) (low vs. high) 0.337 (0.037–3.053) 0.334
CD8+ TILs (post-10 Gy) (low vs. high) 0.187 (0.021–1.703) 0.137

PeLN, lymph node metastasis in pelvis; PALN, para-aortic lymph node metastasis; RT, radiotherapy; TIL, tumor-infiltrating lymphocyte; FIGO, International Federation of Gynecology and Obstetrics.